Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to Paul Drew

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Drew, Paul

Item TypeName
Academic Article PPAR-gamma: Therapeutic Potential for Multiple Sclerosis.
Academic Article Suppression IL-23 and TLR signaling by liver X receptor agonist TO901317 may contribute to its therapeutic effects in EAE
Academic Article Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologies.
Academic Article Peroxisome Proliferator-Activated Receptor-? Agonists: Potential Therapeutics for Neuropathology Associated with Fetal Alcohol Spectrum Disorders.
Grant Effects of Alcohol on Microglia and Innate Immunity
Grant Microglia modulate ethanol impact on CNS development.
Grant Regulation of Neuroimmune Responses in FASD Models
Grant Early Events in Alzheimer Pathogenesis
Grant CNS Development &Alcohol: Microglia-Neuron Interactions
Grant PPAR-gamma Immune Regulation and Multiple Sclerosis
Grant Mechanisms of Ethanol-Induced Neuroinflammation and Neurodegeneration
Grant Alcohol Pathogenesis in CNS Microglial Cells
Grant Neuroinflammatory Mechanisms in FASD: Development of Novel Therapeutic Strategies
Grant PPAR-Agonist as Treatment for Autoimmune Demyelination (Subcontract from UT Southwestern Medical Center)
Grant PPAR-Agonist as Treatment for Autoimmune Demyelination (Subcontract from UT Southwestern Medical Center)
Grant PPAR-alpha agonists as treatment for autoimmune demyelination
Grant LXR agonists as treatment for autoimmune demyelination
Grant LXR agonists as treatment for autoimmune demyelination
Grant PPAR-alpha agonists as treatment for autoimmune demyelination
Grant PPAR-Agonist as Treatment for Autoimmune Demyelination (Subcontract from UT Southwestern Medical Center)
Grant PPAR-alpha agonists as treatment for autoimmune demyelination
Grant LXR agonists as treatment for autoimmune demyelination
Grant LXR agonists as treatment for autoimmune demyelination
Grant PPAR-Agonist as Treatment for Autoimmune Demyelination (Subcontract from UT Southwestern Medical Center)

Search Criteria
  • Therapeutics